SCCM Resource Library-Calling All the Shots: Updates in Trauma Critical Care

Calling All the Shots: Updates in Trauma Critical Care

Video Transcription

Video Summary

Melanie Smith-Kendenny, a clinical pharmacy specialist, reviewed recent pharmacologic strategies in trauma care. She discussed the PROCOAG trial, which assessed the use of four-factor prothrombin complex concentrate (PCC) in trauma patients at risk for massive transfusion. The trial found no clinical benefit and a higher risk of thromboembolic events with PCC addition. She also covered a study comparing aspirin and low-molecular-weight heparin for thromboprophylaxis in orthopedic trauma, revealing aspirin as a non-inferior alternative but not recommended for critically ill patients due to a slight increased risk of DVT.

Asset Caption

Year in Review | Year in Review: Clinical Pharmacy and Pharmacology (Flipped Classroom)

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

trauma care

PROCOAG trial

prothrombin complex concentrate

thromboprophylaxis

orthopedic trauma

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.